{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:47:18Z","timestamp":1755226038354,"version":"3.43.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI111891"],"award-info":[{"award-number":["R01 AI111891"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cell-associated human immunodeficiency virus (HIV) has been found in tissues whose architecture can limit antiretroviral (ARV) drug penetration, including the genital tract.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In healthy and simian-human immunodeficiency virus\u2013infected rhesus macaques dosed for 10 days with 4-drug combination therapy, we evaluated the spatial distribution of 6 ARV drugs within the male and female genital tract by means of mass spectrometric imaging (MSI). We also measured drug transporter gene expression in these tissues to determine their influence of in situ variability of ARV exposure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Through MSI, drug-dependent, heterogeneous ARV accumulation was observed, with preferential accumulation in capsular and epithelial spaces for male and female genital tract tissues, respectively. ARVs were primarily detected as single drug exposure across genital tract tissue sections, with the proportion of tissue where any single ARV was detected (median [range], 58% [5.1%\u201382.3%] for the vagina and 16.6% [3.9%\u201388.4%] for the testis) exceeding the detection of any 2 (13.8% [0.2%\u201330.8%] and 0.9% [0.0%\u201372.8%], respectively) or any 3 (1.8% [0.0%\u20132.5%] and 0.0% [0.0%\u201343.1%]) colocalized ARVs. Most (59.7% [range, 45.8%\u201390.1%]) of the ARV response in vaginal tissue was found to be colocalized with the blood marker heme, suggesting that its origin was from the vasculature rather than parenchymal tissue, while interindividual variability in ARV penetration was higher in testicular tissue.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In both female and male genital tract tissues, ARV penetration did not follow simple trends based solely on molecular size or degree of protein binding, and the combination of MSI and drug transporter expression suggests that multiple mechanisms, including drug transporters, participate in determining local accumulation within this tissue.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf225","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T13:31:48Z","timestamp":1746451908000},"source":"Crossref","is-referenced-by-count":0,"title":["Heterogeneous Antiretroviral Drug Exposure in Male and Female Genital Tract Tissues"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-7281","authenticated-orcid":false,"given":"Elias P","family":"Rosen","sequence":"first","affiliation":[{"name":"Eshelman School of Pharmacy, University of North Carolina at Chapel Hill at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"White","sequence":"additional","affiliation":[{"name":"Eshelman School of Pharmacy, University of North Carolina at Chapel Hill at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Sykes","sequence":"additional","affiliation":[{"name":"Eshelman School of Pharmacy, University of North Carolina at Chapel Hill at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Adamson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, School of Veterinary Medicine, University of California Davis , Davis, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Luciw","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, School of Veterinary Medicine, University of California Davis , Davis, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-5794","authenticated-orcid":false,"given":"Ashlyn","family":"Norris","sequence":"additional","affiliation":[{"name":"Eshelman School of Pharmacy, University of North Carolina at Chapel Hill at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela D M","family":"Kashuba","sequence":"additional","affiliation":[{"name":"Eshelman School of Pharmacy, University of North Carolina at Chapel Hill at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"2025052713005837600_jiaf225-B1","doi-asserted-by":"crossref","first-page":"e00311-19","DOI":"10.1128\/JVI.00311-19","article-title":"Evidence for both intermittent and persistent compartmentalization of HIV-1 in the female genital tract","volume":"93","author":"Mabvakure","year":"2019","journal-title":"J Virol"},{"key":"2025052713005837600_jiaf225-B2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/JVI.79.1.353-363.2005","article-title":"Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination","volume":"79","author":"Philpott","year":"2005","journal-title":"J Virol"},{"key":"2025052713005837600_jiaf225-B3","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1097\/QAD.0000000000001282","article-title":"Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults","volume":"30","author":"Jenabian","year":"2016","journal-title":"AIDS"},{"key":"2025052713005837600_jiaf225-B4","doi-asserted-by":"crossref","first-page":"e00755-19","DOI":"10.1128\/JVI.00755-19","article-title":"HIV diversity and genetic compartmentalization in blood and testes during suppressive antiretroviral therapy","volume":"93","author":"Miller","year":"2019","journal-title":"J Virol"},{"key":"2025052713005837600_jiaf225-B5","doi-asserted-by":"crossref","first-page":"e00229-20","DOI":"10.1128\/JVI.00229-20","article-title":"Compartmentalization and clonal amplification of HIV-1 in the male genital tract characterized using next-generation sequencing","volume":"94","author":"Kariuki Samuel","year":"2020","journal-title":"J Virol"},{"key":"2025052713005837600_jiaf225-B6","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI134815","article-title":"HIV persists throughout deep tissues with repopulation from multiple anatomical sources","volume":"130","author":"Chaillon","year":"2020","journal-title":"J Clin Invest"},{"key":"2025052713005837600_jiaf225-B7","doi-asserted-by":"crossref","first-page":"e00415-20","DOI":"10.1128\/JVI.00415-20","article-title":"HIV RNA rebound in seminal plasma after antiretroviral treatment interruption","volume":"94","author":"Gianella","year":"2020","journal-title":"J Virol"},{"key":"2025052713005837600_jiaf225-B8","doi-asserted-by":"crossref","first-page":"e01639-19","DOI":"10.1128\/AAC.01639-19","article-title":"Antiretroviral penetration across three preclinical animal models and humans in eight putative HIV viral reservoirs","volume":"64","author":"Devanathan","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025052713005837600_jiaf225-B9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3851\/IMP1919","article-title":"Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract","volume":"16","author":"Else","year":"2011","journal-title":"Antivir Ther"},{"key":"2025052713005837600_jiaf225-B10","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1097\/QAI.0b013e3182986ff8","article-title":"Antiretroviral pharmacology in mucosal tissues","volume":"63","author":"Thompson","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025052713005837600_jiaf225-B11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/17425255.2015.1027682","article-title":"Pharmacokinetics of antiretrovirals in mucosal tissue","volume":"11","author":"Cottrell","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2025052713005837600_jiaf225-B12","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1128\/JVI.03628-14","article-title":"Detection of simian immunodeficiency virus in semen, urethra, and male reproductive organs during efficient highly active antiretroviral therapy","volume":"89","author":"Matusali","year":"2015","journal-title":"J Virol"},{"key":"2025052713005837600_jiaf225-B13","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1128\/JVI.01204-13","article-title":"Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues","volume":"87","author":"Massud","year":"2013","journal-title":"J Virol"},{"key":"2025052713005837600_jiaf225-B14","doi-asserted-by":"crossref","first-page":"e1002774","DOI":"10.1371\/journal.ppat.1002774","article-title":"A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model","volume":"8","author":"Shytaj","year":"2012","journal-title":"PloS Pathog"},{"key":"2025052713005837600_jiaf225-B15","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/QAD.0000000000001554","article-title":"Multimodal analysis of drug transporter expression in gastrointestinal tissue","volume":"31","author":"Thompson","year":"2017","journal-title":"AIDS"},{"key":"2025052713005837600_jiaf225-B16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/jpet.119.259150","article-title":"Antiretroviral drug concentrations in lymph nodes: a cross-species comparison of the effect of drug transporter expression, viral infection, and sex in humanized mice, nonhuman primates, and humans","volume":"370","author":"Burgunder","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"2025052713005837600_jiaf225-B17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s13361-014-0884-1","article-title":"Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q exactive and comparison with LC-MS\/MS SRM assay","volume":"25","author":"Barry","year":"2014","journal-title":"J Am Soc Mass Spectrom"},{"key":"2025052713005837600_jiaf225-B18","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1128\/AAC.04952-14","article-title":"Mass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirs","volume":"59","author":"Thompson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2025052713005837600_jiaf225-B19","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00216-014-8220-y","article-title":"Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization","volume":"407","author":"Bokhart","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"2025052713005837600_jiaf225-B20","doi-asserted-by":"crossref","first-page":"e00019-21","DOI":"10.1128\/AAC.00019-21","article-title":"Quantitative imaging analysis of the spatial relationship between antiretrovirals, reverse transcriptase simian-human immunodeficiency virus RNA, and collagen in the mesenteric lymph nodes of nonhuman primates","volume":"65","author":"Scholz","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2025052713005837600_jiaf225-B21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcph.248","article-title":"Expression of six drug transporters in vaginal, cervical, and colorectal tissues: implications for drug disposition in HIV prevention","volume":"54","author":"Nicol","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"2025052713005837600_jiaf225-B22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jconrel.2015.08.018","article-title":"Drug transporters in tissues and cells relevant to sexual transmission of HIV: implications for drug delivery","volume":"219","author":"Hu","year":"2015","journal-title":"J Control Release"},{"key":"2025052713005837600_jiaf225-B23","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/jac\/dkw046","article-title":"Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site","volume":"71","author":"Huang","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2025052713005837600_jiaf225-B24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"2025052713005837600_jiaf225-B25","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1021\/pr4004213","article-title":"Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using NanoUPLC\u2013MS\/MS with selected reaction monitoring","volume":"12","author":"Fallon","year":"2013","journal-title":"J Proteome Res"},{"key":"2025052713005837600_jiaf225-B26","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1128\/AAC.00691-12","article-title":"Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility data","volume":"56","author":"Acosta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"author":"Gilead Sciences","key":"2025052713005837600_jiaf225-B27"},{"author":"Gilead Sciences","key":"2025052713005837600_jiaf225-B28"},{"key":"2025052713005837600_jiaf225-B29","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2025052713005837600_jiaf225-B30","doi-asserted-by":"crossref","first-page":"eaap8758","DOI":"10.1126\/scitranslmed.aap8758","article-title":"Heterogeneous antiretroviral drug distribution and HIV\/SHIV detection in the gut of three species","volume":"11","author":"Thompson","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025052713005837600_jiaf225-B31","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/srep02859","article-title":"Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging","volume":"3","author":"Liu","year":"2013","journal-title":"Sci Rep"},{"key":"2025052713005837600_jiaf225-B32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/clpt.2010.189","article-title":"Pharmacologic opportunities for HIV prevention","volume":"88","author":"Nicol","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"2025052713005837600_jiaf225-B33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/QAI.0000000000000996","article-title":"Cervicovaginal and rectal fluid as a surrogate marker of antiretroviral tissue concentration: implications for clinical trial design","volume":"72","author":"Cottrell","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025052713005837600_jiaf225-B34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QAI.0b013e3181ae69c5","article-title":"Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women","volume":"51","author":"Dumond","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025052713005837600_jiaf225-B35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/infdis\/jiw077","article-title":"A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine","volume":"214","author":"Cottrell","year":"2016","journal-title":"J Infect Dis"},{"key":"2025052713005837600_jiaf225-B36","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/jac\/dkae216","article-title":"Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates","volume":"79","author":"Gel\u00e9","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2025052713005837600_jiaf225-B37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug\u2013drug interactions: role of ABC and SLC transporters","volume":"31","author":"Kis","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"2025052713005837600_jiaf225-B38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1208\/s12248-020-00498-1","article-title":"HIV-1 sanctuary sites\u2014the role of membrane-associated drug transporters and drug metabolic enzymes","volume":"22","author":"Whyte-Allman","year":"2020","journal-title":"AAPS J"},{"key":"2025052713005837600_jiaf225-B39","doi-asserted-by":"crossref","first-page":"E2874","DOI":"10.1073\/pnas.1424184112","article-title":"Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance","volume":"112","author":"Moreno-Gamez","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025052713005837600_jiaf225-B40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/COH.0000000000000741","article-title":"HIV drug resistance in various body compartments","volume":"17","author":"Van Zyl","year":"2022","journal-title":"Curr Opin HIV AIDS"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf225\/63053071\/jiaf225.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf225\/63053071\/jiaf225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:03:29Z","timestamp":1748365409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiaf225\/8124864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf225","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"article-number":"jiaf225"}}